These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33820679)

  • 1. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies.
    Tarricone R; Amatucci F; Armeni P; Banks H; Borsoi L; Callea G; Ciani O; Costa F; Federici C; Torbica A; Marletta M
    Health Policy; 2021 May; 125(5):602-608. PubMed ID: 33820679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HTA and procurement practices on the selection and prices of medical devices.
    Callea G; Armeni P; Marsilio M; Jommi C; Tarricone R
    Soc Sci Med; 2017 Feb; 174():89-95. PubMed ID: 28013109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing the introduction of genomic applications into the National Health Service: A special challenge for health technology assessment in Italy.
    Pitini E; Migliara G; Baccolini V; Isonne C; Mazzalai E; Turatto F; Salerno C; Pagano F; Menzano MT; De Vito C; Marzuillo C; Villari P
    Front Public Health; 2022; 10():932093. PubMed ID: 36033790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations.
    Hoxhaj I; Castagna C; Calabrò GE; Boccia S
    Front Public Health; 2022; 10():795763. PubMed ID: 35223734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges.
    Daubner-Bendes R; Kovács S; Niewada M; Huic M; Drummond M; Ciani O; Blankart CR; Mandrik O; Torbica A; Yfantopoulos J; Petrova G; Holownia-Voloskova M; Taylor RS; Al M; Piniazhko O; Lorenzovici L; Tarricone R; Zemplényi A; Kaló Z
    Front Public Health; 2020; 8():612410. PubMed ID: 33490024
    [No Abstract]   [Full Text] [Related]  

  • 8. An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations.
    Tarricone R; Banks H; Ciani O; Brouwer W; Drummond MF; Leidl R; Martelli N; Sampietro-Colom L; Taylor RS
    Expert Rev Med Devices; 2023 Apr; 20(4):259-271. PubMed ID: 36987818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis.
    Woodford Guegan E; Cook A
    Health Technol Assess; 2014 Jun; 18(37):1-296. PubMed ID: 24913263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].
    Mittermayer R; Huić M; Mestrović J
    Acta Med Croatica; 2010 Dec; 64(5):425-34. PubMed ID: 21692267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?
    Chassagnol F; Marcelli G; Wagle J; Giuliani G; Traub D; Schaub V; Ruof J
    Health Policy; 2020 Sep; 124(9):943-951. PubMed ID: 32622542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging EUnetHTA's conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer's point of view.
    Giuliani G; Chassagnol F; Traub D; Gyldmark M; Hebborn A; Ducournau P; Ruof J
    Health Econ Rev; 2018 Sep; 8(1):24. PubMed ID: 30242522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disinvestment in healthcare: an overview of HTA agencies and organizations activities at European level.
    Calabrò GE; La Torre G; de Waure C; Villari P; Federici A; Ricciardi W; Specchia ML
    BMC Health Serv Res; 2018 Mar; 18(1):148. PubMed ID: 29490647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
    Kahveci R; Koç EM; Küçük EÖ
    Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments.
    Ciani O; Wilcher B; van Giessen A; Taylor RS
    Health Econ; 2017 Feb; 26 Suppl 1():13-29. PubMed ID: 28139087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health technology assessment of medical devices: a survey of non-European union agencies.
    Ciani O; Wilcher B; Blankart CR; Hatz M; Rupel VP; Erker RS; Varabyova Y; Taylor RS
    Int J Technol Assess Health Care; 2015 Jan; 31(3):154-65. PubMed ID: 26044729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group Report.
    Perugini M; Johnson TJ; Beume TM; Dong OM; Guerino J; Hu H; Kerr K; Kindilien S; Nuijten M; Ofili TU; Taylor M; Wong A; Freijer K
    Value Health; 2022 May; 25(5):677-684. PubMed ID: 35500942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3.
    Garrett Z; Imaz-Iglesia I; Willemsen A
    Int J Technol Assess Health Care; 2022 Jan; 38(1):e14. PubMed ID: 35086599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [European Collaboration in Medical Device Assessment: One Step Towards Cross-Border Health Care].
    Mayer J; Ettinger S; Nachtnebel A
    Gesundheitswesen; 2018 Mar; 80(3):210-216. PubMed ID: 28628932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.